Invesco Ltd. Buys 12,489 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Invesco Ltd. lifted its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 12.4% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 113,153 shares of the medical instruments supplier's stock after purchasing an additional 12,489 shares during the quarter. Invesco Ltd. owned 0.46% of ICU Medical worth $17,558,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also recently modified their holdings of ICUI. Harvest Fund Management Co. Ltd bought a new position in shares of ICU Medical during the 4th quarter valued at $33,000. Murphy & Mullick Capital Management Corp purchased a new position in ICU Medical in the fourth quarter worth about $52,000. Venturi Wealth Management LLC increased its position in shares of ICU Medical by 64.0% during the 4th quarter. Venturi Wealth Management LLC now owns 528 shares of the medical instruments supplier's stock valued at $82,000 after purchasing an additional 206 shares during the last quarter. Russell Investments Group Ltd. lifted its stake in shares of ICU Medical by 88.8% in the 4th quarter. Russell Investments Group Ltd. now owns 638 shares of the medical instruments supplier's stock worth $99,000 after purchasing an additional 300 shares during the period. Finally, Smartleaf Asset Management LLC boosted its holdings in shares of ICU Medical by 166.8% in the fourth quarter. Smartleaf Asset Management LLC now owns 907 shares of the medical instruments supplier's stock worth $140,000 after buying an additional 567 shares during the last quarter. 96.10% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts recently issued reports on ICUI shares. StockNews.com upgraded ICU Medical from a "hold" rating to a "buy" rating in a research note on Wednesday, April 16th. Raymond James set a $97.00 price objective on shares of ICU Medical in a research report on Wednesday, March 12th. Needham & Company LLC reaffirmed a "hold" rating on shares of ICU Medical in a report on Tuesday, April 8th. Finally, KeyCorp decreased their price target on ICU Medical from $209.00 to $191.00 and set an "overweight" rating on the stock in a report on Monday. One research analyst has rated the stock with a hold rating, three have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, ICU Medical currently has a consensus rating of "Buy" and a consensus price target of $162.67.

ICU Medical Price Performance

Shares of NASDAQ:ICUI traded up $4.42 during mid-day trading on Thursday, reaching $136.70. The stock had a trading volume of 231,977 shares, compared to its average volume of 265,216. The company has a market cap of $3.35 billion, a P/E ratio of -29.91 and a beta of 0.86. ICU Medical, Inc. has a 1 year low of $93.36 and a 1 year high of $196.26. The business's 50 day moving average price is $144.83 and its 200 day moving average price is $158.80. The company has a current ratio of 2.29, a quick ratio of 1.03 and a debt-to-equity ratio of 0.75.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.